Does Zepbound Cause Constipation? A Doctor Explains

Constipation is one of the most frequently reported side effects of Zepbound (tirzepatide), a dual-action GLP-1 and GIP receptor agonist approved for chronic weight management and type 2 diabetes. As an endocrinologist, I often counsel patients that while Zepbound offers significant metabolic benefits—including improved glycemic control and sustained weight loss—its effects on gastrointestinal motility can lead to uncomfortable constipation. Understanding why this occurs, how common it is, and how to manage it effectively can help patients stay on track with their treatment while minimizing discomfort.

Why Does Zepbound Cause Constipation?

Zepbound causes constipation primarily through its mechanism of action on gastrointestinal function. As a GLP-1 receptor agonist, Zepbound slows gastric emptying and intestinal transit time, which helps promote satiety and reduce food intake. However, this delay in digestion can lead to harder, less frequent stools. Additionally, Zepbound influences fluid absorption in the intestines, further contributing to stool dryness. Tirzepatide, the active ingredient in Zepbound, also activates GIP receptors, which may modulate gut motility in ways that exacerbate constipation in some individuals.

Clinical trials have consistently shown that gastrointestinal side effects, including constipation, are dose-dependent and more pronounced during dose escalation. The slowing of gut motility is a well-documented effect of GLP-1-based therapies, and Zepbound is no exception. While this mechanism is beneficial for weight loss and glucose control, it can lead to discomfort if not proactively managed.

How Common Is Constipation on Zepbound?

Constipation is a common side effect of Zepbound, with clinical data providing clear insights into its prevalence. In the SURMOUNT-1 trial, which evaluated Zepbound for weight loss, constipation was reported in approximately 17% of participants receiving the 5 mg dose, 19% at 10 mg, and 22% at the 15 mg dose. In diabetes-focused SURPASS trials, constipation rates ranged from 6% to 12%, depending on the dose. These figures suggest that constipation occurs in roughly 1 in 5 to 1 in 8 patients using Zepbound, making it one of the most frequent Zepbound side effects.

The variation in reported rates may reflect differences in study populations, dosing regimens, and individual susceptibility. Patients with pre-existing gastrointestinal conditions or those who are less physically active may be at higher risk. Importantly, constipation is more likely to occur during the initial weeks of treatment or following dose increases, as the body adjusts to Zepbound’s effects on gut motility.

How Long Does Zepbound Constipation Last?

For most patients, Zepbound-related constipation is temporary and improves over time. In clinical trials, the majority of gastrointestinal side effects, including constipation, peaked within the first 4 to 8 weeks of treatment and gradually diminished as the body adapted to the medication. Many patients report significant improvement in bowel habits after 12 weeks of consistent use, particularly if they implement dietary and lifestyle modifications.

However, the duration of constipation can vary. Some individuals may experience persistent symptoms, especially if they remain on a stable dose without addressing contributing factors like low fiber intake or dehydration. It’s also worth noting that dose escalations—common in Zepbound’s titration schedule—can trigger transient constipation as the gastrointestinal system readjusts. Patients should be reassured that while constipation may be bothersome, it often resolves with time and proactive management.

How to Manage Constipation While Taking Zepbound

Managing constipation while on Zepbound involves a combination of dietary adjustments, hydration, physical activity, and, if necessary, over-the-counter remedies. First, increasing dietary fiber is essential. Soluble fiber sources like oats, beans, apples, and flaxseeds can soften stools and promote regularity. Aim for 25 to 35 grams of fiber per day, but increase intake gradually to avoid bloating. Hydration is equally critical; patients should drink at least 2 to 3 liters of water daily, as Zepbound can reduce fluid intake by suppressing appetite.

Regular physical activity, such as walking or yoga, stimulates intestinal motility and can counteract the slowing effects of Zepbound on the gut. For those who need additional relief, osmotic laxatives like polyethylene glycol (Miralax) or stool softeners such as docusate sodium can be effective. Stimulant laxatives (e.g., senna or bisacodyl) should be used sparingly and only as a short-term solution. Probiotics may also help by supporting a healthy gut microbiome, though evidence for their efficacy in Zepbound-induced constipation is limited.

When to See Your Doctor About Zepbound and Constipation

While constipation is a common and often manageable side effect of Zepbound, there are instances when medical attention is warranted. Patients should consult their healthcare provider if constipation persists for more than 2 weeks despite dietary and lifestyle interventions, or if it is accompanied by severe symptoms such as abdominal pain, bloating, nausea, or vomiting. These could indicate a more serious condition, such as bowel obstruction, particularly in patients with a history of gastrointestinal disorders.

Additionally, if constipation leads to complications like hemorrhoids, anal fissures, or rectal bleeding, a doctor’s evaluation is necessary. Patients should also seek medical advice if they experience unexplained weight loss, fatigue, or signs of dehydration (e.g., dark urine, dizziness), as these may signal an underlying issue. In some cases, adjusting the Zepbound dose or temporarily pausing treatment may be considered to alleviate severe symptoms.

Zepbound Constipation vs Other GLP-1 Side Effects

Constipation is just one of several gastrointestinal side effects associated with Zepbound and other GLP-1 receptor agonists. Compared to nausea and vomiting—which are more commonly reported, particularly during dose escalation—constipation tends to be less acute but more persistent. While nausea often resolves within a few weeks, constipation may linger, especially if not actively managed. Other Zepbound side effects, such as diarrhea or abdominal discomfort, can coexist with constipation, creating a confusing clinical picture.

Unlike semaglutide (Wegovy, Ozempic) or liraglutide (Saxenda), Zepbound has a dual mechanism of action, targeting both GLP-1 and GIP receptors. This may contribute to a slightly different side effect profile, though constipation remains a shared concern across GLP-1-based therapies. Patients switching from another GLP-1 agonist to Zepbound may notice differences in the severity or duration of constipation, as individual responses to these medications vary.

Does Zepbound Dosage Affect Constipation?

The dosage of Zepbound plays a significant role in the likelihood and severity of constipation. Clinical trials demonstrate a clear dose-response relationship: higher doses of Zepbound are associated with increased rates of constipation. For example, in the SURMOUNT-1 trial, constipation was reported in 17% of patients on the 5 mg dose, compared to 22% on the 15 mg dose. This trend reflects the medication’s dose-dependent effects on gastric emptying and intestinal motility.

Patients initiating Zepbound typically start at a low dose (2.5 mg) and gradually titrate upward over several weeks. This slow escalation helps mitigate side effects, including constipation, by allowing the gastrointestinal system to adapt. However, even with gradual titration, some patients may experience worsening constipation with each dose increase. If constipation becomes intolerable, healthcare providers may consider extending the titration schedule or temporarily reducing the dose to improve tolerability.

Frequently Asked Questions

Does Zepbound cause constipation in everyone?

No, Zepbound does not cause constipation in everyone. While it is a common side effect, affecting roughly 1 in 5 to 1 in 8 patients, individual responses vary. Factors such as diet, hydration, physical activity, and pre-existing gastrointestinal conditions influence whether a patient will experience constipation while taking Zepbound.

How long does constipation last on Zepbound?

For most patients, Zepbound-related constipation is temporary and improves within 4 to 12 weeks of starting treatment. However, some individuals may experience persistent symptoms, particularly if they do not address contributing factors like low fiber intake or dehydration. Dose increases can also trigger transient constipation as the body adjusts.

Can you prevent constipation on Zepbound?

While constipation cannot always be prevented, its severity can often be reduced with proactive measures. Increasing dietary fiber, staying hydrated, engaging in regular physical activity, and using over-the-counter stool softeners or laxatives as needed can help manage or prevent constipation while taking Zepbound.

Is constipation a reason to stop Zepbound?

Constipation alone is rarely a reason to discontinue Zepbound, especially if it is mild to moderate and improves with management. However, if constipation is severe, persistent, or accompanied by complications like abdominal pain or rectal bleeding, patients should consult their healthcare provider to discuss potential dose adjustments or alternative treatments.

Disclaimer from Dr. Nina Patel: The information provided in this article is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before starting, stopping, or adjusting any medication, including Zepbound (tirzepatide). Individual responses to medications vary, and your doctor can provide personalized guidance based on your health status and needs.